Document Detail


Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.
MedLine Citation:
PMID:  1891776     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The pharmacokinetics of trichloroethylene (TCE) was characterized during and following inhalation exposures of male Sprague-Dawley rats. The blood and exhaled breath TCE time-course data were used to formulate and assess the accuracy of predictions of a physiologically based pharmacokinetic (PB-PK) model for TCE inhalation. Fifty or 500 ppm of TCE was inhaled by unanesthetized rats of 325-375 g for 2 hr through a miniaturized one-way breathing valve. Repetitive samples of the inhaled and exhaled breath streams, as well as arterial blood, were collected concurrently during and for 3 hr following the exposures and analyzed for TCE by headspace gas chromatography. Respiratory rates and volumes were continuously monitored and used in conjunction with the pharmacokinetic data to delineate uptake and elimination profiles. Levels of TCE in the exhaled breath attained near steady-state soon after the beginning of exposures, and were then directly proportional to the inhaled concentration. Exhaled breath levels of TCE in rats were similar in magnitude to values previously published for TCE inhalation exposures of humans. Levels of TCE in the blood of the 50 ppm-exposed animals also rapidly approached near steady-state, but blood levels in the 500 ppm-exposed animals rose progressively, reaching concentrations 25- to 30-fold higher than in the 50 ppm group during the second hour of exposure. The 10-fold increase in inhaled concentration resulted in an 8.7-fold increase in cumulative uptake, or total absorbed dose. These findings of nonlinearity indicate that metabolic saturation ensued during the 500 ppm exposure. The PB-PK model was characterized as blood flow-limited with TCE eliminated unchanged in the exhaled breath and by saturable liver metabolism. The uptake and elimination profiles were accurately simulated by the PB-PK model for both the 50 and 500 ppm TCE exposure levels. Such a model may be quite useful in risk assessments in predicting internal (i.e., systemically absorbed) doses of TCE and other volatile organics under a variety of exposure scenarios.
Authors:
C E Dallas; J M Gallo; R Ramanathan; S Muralidhara; J V Bruckner
Related Documents :
11415956 - Tofu consumption and blood lead levels in young chinese adults.
18518986 - Re-evaluation of blood mercury, lead and cadmium concentrations in the inuit population...
16093526 - Uptake and disposition of inhaled methanol vapor in humans.
7795756 - Dose-response relation between exposure to two types of hand-arm vibration and sensorin...
3194926 - Changing patterns of blood transfusions in four sets of united states hospitals, 1980 t...
9024826 - Hepatic influence on pulmonary neutrophil sequestration following intestinal ischemia-r...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.    
Journal Detail:
Title:  Toxicology and applied pharmacology     Volume:  110     ISSN:  0041-008X     ISO Abbreviation:  Toxicol. Appl. Pharmacol.     Publication Date:  1991 Sep 
Date Detail:
Created Date:  1991-10-17     Completed Date:  1991-10-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0416575     Medline TA:  Toxicol Appl Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  303-14     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology College of Pharmacy, University of Georgia, Athens 30602.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Animals
Male
Models, Biological
Organ Specificity
Rats
Rats, Inbred Strains
Regional Blood Flow
Respiration
Time Factors
Trichloroethylene / administration & dosage,  blood,  pharmacokinetics*
Chemical
Reg. No./Substance:
79-01-6/Trichloroethylene

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Metabolic effects of pivalate in isolated rat hepatocytes.
Next Document:  Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung.